The Joint Blog

JANUARY 28, 2020

“You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” Cornell University veterinary researcher Joseph Wakshlag, who studies therapeutic uses for the compound, told the Associated Press. “Or billion by 2023, according to the cannabis research firm Brightfield Group.”

Pets 26

Pets CBD Research and Development Oil 26

The Joint Blog

JANUARY 12, 2020

The market for CBD pet products has exploded in recent years, with numerous success stories. However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. Because the federal government has yet to establish standards for CBD, these companies can get away with it.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Cannabis Law Report

JUNE 16, 2022

Recent reports from Hong Kong have shown that the authorities don’t appear overly enamoured with CBD products and like everybody else we, at CLR, are clueless as to the reality of CBD “legality” on the mainland. Energy Hemp is planned for Hong Kong in 2023. Sounds fantastic doesn’t it.

eCommerce 52

eCommerce Hemp Extraction CBD 52

Cannabis Law Report

JULY 1, 2022

Oregon’s impending ban comes just months after the United States Court of Appeals for the Ninth Circuit (whose jurisdiction includes Oregon) ruled that Delta-8 THC (an ADC) is legal under federal law. CBN is currently the most popular ADC and many consumers take the product as a sleeping aid. Impact on Industry & CBN.

Cannabinoids 52

Cannabinoids Dispensary Edibles THC 52

The Cannigma

AUGUST 14, 2023

Sleep is essential for overall health and well-being, and yet, many of us struggle to get a restful night’s sleep. From the daily stressors of life to hormonal changes, various factors can disrupt sleep patterns, especially for perimenopausal women. So, what’s a woman to do? But we’re not completely blind.

Sleep 68

Sleep CBD Cannabinoids THC 68

United Patients Group

DECEMBER 15, 2023

There is a stubborn stigma surrounding Cannabis and it no longer is simply that Cannabis has no merit or is an entrance drug, but that the non-psychoactive cannabinoid, CBD, is ALL you need for health, wellness, and other ailments which is not totally true. The same goes for using CBD only, we leave out other important cannabinoids.

CBD 119

CBD Terpenes Wellness and Beauty Cannabinoids 119

MMJ Recs

OCTOBER 5, 2023

In Maryland dispensaries, patients can find a wide selection of strains with different THC (tetrahydrocannabinol) and CBD (cannabidiol) ratios. CBD Oil in Maryland CBD (cannabidiol) oil is a non-psychoactive component of cannabis known for its potential therapeutic benefits.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Law Report

NOVEMBER 11, 2021

The amendment marks the final regulatory step required to launch the company’s direct to consumer website, allowing patients across Canada to order online the unique patented exact dosage hard tablets and caplets of THC and CBD in various strengths. Each consultant received 60,000 options. OCS Order Schedule.

Events 52

Events Pharmaceutical Cannabinoids Patients 52

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

MAY 24, 2023

And this month comes a brand-new paper in the journal Biochemical Pharmacology 3 by Israeli researchers who report that three cannabis terpenes — at concentrations similar to those found in actual cannabis plants — significantly boost THC signaling at the CB1 receptor. This is notable in and of itself, though not a huge surprise.

Terpenes 274

Terpenes THC Cannabinoids Concentrates 274

Project CBD

JUNE 20, 2023

Pain, anxiety, and sleep are major drivers of medical cannabis use. The concentration of cannabinoid receptors in the gut also helps to explain cannabis hyperemesis syndrome , in which an overabundance of exogenous cannabinoids, particularly THC, triggers debilitating nausea, vomiting, and pain that typically resolves when cannabis use stops.)

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

The Cannigma

OCTOBER 22, 2023

Related Stories Real world data: CBD with CBN, THC, and melatonin is a winning formula for sleep Here’s what you need to know about cannabis research Does cannabis have calories? Gathering large consumer data sets and interpreting them appropriately can help us make the learning faster and cheaper.

Data 92

Data Research and Development Sleep Collective 92

Cannabis Law Report

JUNE 1, 2021

In Beverages, The Company launched a portfolio of THC beverages in the Canadian recreational cannabis market during FY 2021, capturing 35% dollar share of the total beverage category during the full year. Canopy Growth launched Quatreau CBD beverages in Canada in Q3 2021 and captured #1 market share in Canada since launch.

Data 95

Data Vaping Supply Chain Business 95

Illinois News Joint

MARCH 11, 2024

Arianne Richards, Executive Director of Chicago NORML, spoke next about what she regarded as, the “troubling mishandling of the petitions submitted in July 2023 to include four women’s health conditions on the list of qualifying conditions for the Medical Cannabis Program.” “Our

Conditions 111

Conditions Advocacy Patients Programs 111

Cannabis Law Report

AUGUST 6, 2021

presence through broad portfolio of innovative CBD and CPG brands. We’re continuing to drive cost savings and operational efficiencies across the company, and remain broadly on track to our target of $150 – $200 million in fiscal 2022- fiscal 2023,” added Mike Lee , CFO. “We First Quarter Fiscal 2022 Financial Summary. in Q1 2022.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed HB 324 , which establishes a regulatory commission to oversee the eventual “production, manufacturing, and dispensing” of products possessing specified quantities of plant-derived THC to qualified patients. The law went into effect on July 1, 2019. The law will take effect on January 1, 2020.

Legislation 59

Legislation Patients Access Banking 59